Bristle
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- $3M
Investors
- 2
About Bristle
a. Bristle is a health-tech company that provides at-home saliva tests for oral health to measure the bacteria that cause bad breath, tooth decay, and gum inflammation. In July 2022, Bristle, Inc. The company provides an oral health test kit that measures more than 100 bacteria in an individual’s saliva that contribute to tooth decay, gum inflammation, and halitosis (bad breath). Once conducting the test, individuals can reach the company’s oral health experts to get a care plan, personalized diet plan, and products and hygiene recommendations. Bristle generates revenue from the sale of oral health test kits through its online platform at USD 119. The company is planning to explore the potential to add B2B (business to business) lines of business.
Who invested in Bristle
2 investors across 1 round
See all investors in Bristle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 25, 2022
Amount
$3M
Investors
Questions about Bristle
Who invested in Bristle?
Bristle has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bristle raised?
Bristle has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bristle last raise money?
Bristle's most recent round on record is a Seed, in Jul 2022.
What does Bristle do?
Bristle is a medical devices & equipment company.
Where is Bristle headquartered?
Bristle is headquartered in San Francisco, US.
Which VCs invest in companies like Bristle?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Bristle's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Bristle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.